|
|
||||||||
Ann Thorac Surg 2001;71:735-736
© 2001 The Society of Thoracic Surgeons
a Divisions of Perfusion Services, Duke University Medical Center and Health Systems, Durham, North Carolina, USA
b Thoracic Surgery, Duke University Medical Center and Health Systems, Durham, North Carolina, USA
Accepted for publication June 2, 2000.
Address reprint requests to Dr Ungerleider, Division of Cardiothoracic Surgery, L-353, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, Portland, OR 97201-3098
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In instances of post-cardiopulmonary bypass ventricular dysfunction with single ventricle morphology in neonates who require mechanical support, it may be beneficial to eliminate the oxygenator from the standard ECMO system. In this configuration, the circuit becomes a roller pump ventricular assist device. We have used the term NOMO-VAD for "No membrane oxygenator-ventricular assist device." This system, as opposed to centrifugal pump systems, retains the desirable aspects of the ECMO circuit including pump servo-regulation, pressure monitoring, access ports for fluid/drug administration, air bubble detection, in-line blood gas monitoring, and a heat exchanger. Oxygenation is provided by the infants own lungs, simply by leaving the aortopulmonary shunt open [3].
| Technique |
|---|
|
|
|---|
The NOMO-VAD set-up is done in the same fashion as a standard ECMO system with one exception; a
x
inch tubing connector is substituted in place of the oxygenator. This circuit is primed per ECMO protocol although less blood products may be necessary due to the reduction of prime volume resulting from the elimination of the oxygenator. Cannulation utilizes the same cannulae used for the surgical reconstruction with venous return from the right atrium and arterial infusion into the neoaorta. Initiation of NOMO-VAD should be done slowly since the circuit prime is not oxygenated. Target flow rates of 200 ml/kg/min should be achieved in order to support the dual circulations (systemic and pulmonary) present in Stage I palliation patients [3]. Monitoring and volume management of the NOMO-VAD system and patient would follow standard ECMO protocol. Since there is no oxygenator in the circuit, and flow rates are generally high, anticoagulation may not be essential and is usually not desirable in the first several hours after surgery. This promotes hemostasis in these patients who can often exhibit substantial bleeding due to the extensive suture lines. After hemostasis is secure, anticoagulation can be provided by infusion of heparin to maintain the activated clotting time at 180 to 200 seconds. The chest incision is usually covered with an eshmark dressing while the cannulae are in place. Patients often benefit from support for 2 to 5 days and then can be easily weaned, decannulated, and have chest closure in the intensive care unit. Weaning from NOMO-VAD is simple since the patients aortopulmonary shunt is open and cessation of VAD flow restores the patients to standard Stage I physiology. Since the circuit has an arterio-venous loop, flow through the system can be maintained while it is ascertained whether the patient is ready to be separated from the circuit.
We have now utilized this system for 5 (nonconsecutive) infants who have undergone Norwood Stage I palliation procedures. Four of these infants were placed on VAD in the operating room because of signs of deteriorating myocardial function during or immediately following a period of modified ultrafiltration. Deterioration in myocardial function was manifested by falling blood pressures, a need for increasing inotropic support beyond dopamine (10 µg/kg/min), a decrease in arterial oxygenation below 70% or (in 2 cases) cardiac arrest requiring reinstitution of cardiopulmonary bypass. One patient had deterioration in the intensive care unit on the first postoperative day despite an initially smooth clinical course. After resuscitation with epinephrine, this patient was placed on NOMO-VAD in the intensive care unit. The NOMO-VAD course was 2 to 5 days. In 2 patients who could not be weaned at 2 days, echocardiogram performed at 5 days revealed large posterior pericardial effusions which, once drained, enabled easy weaning from the circuit. It was suspected that these probably interfered with the attempt at weaning after 2 days of support. One patient, who had had a cardiac arrest in the operating room, required 5 days of NOMO-VAD support before he could be weaned. From this experience, we would suggest performing an echocardiogram on any infant who cannot be weaned after 2 days of support to rule out the presence of a large posterior pericardial effusion. One patient died in the hospital due to problems not related to his cardiovascular system. The other 4 patients have been discharged from the hospital and have all undergone successful bidirectional Glenn procedures.
There have been no complications related to the NOMO-VAD circuitry. In all cases, we were able to maintain support at flow rates of 150 to 200 ml/min with normal arterial blood gases. Manipulation of the ventilator to control shunt balance in these patients was not necessary.
| Comment |
|---|
|
|
|---|
The use of ECMO circuitry, equipment, and personnel makes the NOMO-VAD technique a simple and versatile way to provide cardiac support to this "physiologically challenged" population of patients. The elimination of the oxygenator may have the positive benefits in reducing associated thromboemboli, preserving coagulation factors, minimizing hemolysis, and reducing the inflammatory response [5, 6]. Despite our somewhat limited clinical experience, we are encouraged by the simplicity of this technique and report it because of its potential for enormous value in helping improve survival rates for this challenging group of patients. Support of the increased cardiac output needs following Norwood Stage I palliation may not only lead to increased survival, but protects the infant from hemodynamic instability and diminished tissue oxygen delivery from low cardiac output in the immediate postoperative period. This may lead to improved long-term outcomes.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Hoskote, D. Bohn, C. Gruenwald, D. Edgell, S. Cai, I. Adatia, and G. Van Arsdell Extracorporeal life support after staged palliation of a functional single ventricle: Subsequent morbidity and survival J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1114 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Alsoufi, I. Shen, T. Karamlou, C. Giacomuzzi, G. Burch, M. Silberbach, and R. Ungerleider Extracorporeal Life Support in Neonates, Infants, and Children After Repair of Congenital Heart Disease: Modern Era Results in a Single Institution Ann. Thorac. Surg., July 1, 2005; 80(1): 15 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Mahle, J. M. Forbess, P. M. Kirshbom, A. R. Cuadrado, J. M. Simsic, and K. R. Kanter Cost-utility analysis of salvage cardiac extracorporeal membrane oxygenation in children J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1084 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
R R Chaturvedi, D Macrae, K L Brown, M Schindler, E C Smith, K B Davis, G Cohen, V Tsang, M Elliott, M de Leval, et al. Cardiac ECMO for biventricular hearts after paediatric open heart surgery Heart, May 1, 2004; 90(5): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Ungerleider, I. Shen, T. Yeh Jr, J. Schultz, R. Butler, M. Silberbach, C. Giacomuzzi, E. Heller, L. Studenberg, B. Mejak, et al. Routine mechanical ventricular assist following the Norwood procedure--improved neurologic outcome and excellent hospital survival Ann. Thorac. Surg., January 1, 2004; 77(1): 18 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Kolovos, S. L. Bratton, F. W. Moler, E. L. Bove, R. G. Ohye, R. H. Bartlett, and T. J. Kulik Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery Ann. Thorac. Surg., November 1, 2003; 76(5): 1435 - 1441. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |